[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:integrin":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Integrin",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04665947","First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer",[11],"Early Phase 1","RECRUITING","2026-08-26T02:15:56.561131Z","2026-04-29T02:57:57.105988Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06389123","Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas",[19],"Phase 1","2026-08-26T02:17:39.048487Z","2026-05-05T02:43:29.368418Z"]